David Urech

Person

Hombrechtikon, CH

People

Patents Grantslast 30 patents

Information Patent Grant
Hetero-dimeric multi-specific antibody format targeting at least CD...
- Patent number 12,098,203
- Issue date Sep 24, 2024
- Numab Therapeutics AG
- David Urech
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Hetero-dimeric multi-specific antibody format
- Patent number 11,879,005
- Issue date Jan 23, 2024
- Numab Therapeutics AG
- Sebastian Meyer
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Humanization of rabbit antibodies using a universal antibody framework
- Patent number 11,858,981
- Issue date Jan 2, 2024
- Novartis AG
- Leonardo Borras
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Stable and soluble antibodies inhibiting TNFα
- Patent number 11,578,123
- Issue date Feb 14, 2023
- Novartis AG
- Leonardo Borras
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Antibody frameworks
- Patent number 11,427,628
- Issue date Aug 30, 2022
- Numab Therapeutics AG
- Sebastian Meyer
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Stable antibody variable domain framework combinations and methods...
- Patent number 11,421,035
- Issue date Aug 23, 2022
- Numab Therapeutics AG
- Dania Diem
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Anti-CD3 antibodies
- Patent number 11,319,371
- Issue date May 3, 2022
- Numab Therapeutics AG
- Tea Gunde
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Hetero-dimeric multi-specific antibody format
- Patent number 11,236,150
- Issue date Feb 1, 2022
- Numab Therapeutics AG
- Sebastian Meyer
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Solubility optimization of immunobinders
- Patent number 11,046,757
- Issue date Jun 29, 2021
- Novartis AG
- Leonardo Borras
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Method for decreasing immunogenicity
- Patent number 10,781,268
- Issue date Sep 22, 2020
- Novartis AG
- David Urech
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Stable and soluble antibodies inhibiting VEGF
- Patent number 10,590,193
- Issue date Mar 17, 2020
- Novartis AG
- Leonardo Borras
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Stable and soluble antibodies
- Patent number 10,570,198
- Issue date Feb 25, 2020
- Novartis AG
- Leonardo Jose Borras
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Solubility optimization of immunobinders
- Patent number 10,221,237
- Issue date Mar 5, 2019
- ESBATech, an Alcon Biomedical Research Unit LLC
- Leonardo Borras
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Antibody frameworks
- Patent number 10,174,102
- Issue date Jan 8, 2019
- Numab Innovation AG
- Sebastian Meyer
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Stable and soluble antibodies inhibiting TNF alpha
- Patent number 10,100,111
- Issue date Oct 16, 2018
- ESBATech, an Alcon Biomedical Research Unit LLC
- Leonardo Borras
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Humanization of rabbit antibodies using a universal antibody framework
- Patent number 10,087,244
- Issue date Oct 2, 2018
- ESBATech, an Alcon Biomedical Research Unit LLC
- Leonardo Jose Borras
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
CD3 and IL-23 receptor binding bispecific constructs and their use...
- Patent number 10,077,312
- Issue date Sep 18, 2018
- Numab Therapeutics AG
- David Urech
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Sequence based engineering and optimization of single chain antibodies
- Patent number 9,938,336
- Issue date Apr 10, 2018
- ESBATech, an Alcon Biomedical Research Unit LLC
- David M. Urech
- G06 - COMPUTING CALCULATING COUNTING
Information Patent Grant
Sequence based engineering and optimization of single chain antibodies
- Patent number 9,908,945
- Issue date Mar 6, 2018
- ESBATech, an Alcon Biomedical Research Unit LLC
- David Urech
- G06 - COMPUTING CALCULATING COUNTING
Information Patent Grant
Humanized immunobinders of cell-surface antigens
- Patent number 9,908,940
- Issue date Mar 6, 2018
- ESBATech, an Alcon Biomedical Research Unit LLC
- David Urech
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Stable and soluble antibodies inhibiting VEGF
- Patent number 9,873,737
- Issue date Jan 23, 2018
- ESBATech, an Alcon Biomedical Research Unit LLC
- Leonardo Borras
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Method for decreasing immunogenicity
- Patent number 9,803,027
- Issue date Oct 31, 2017
- ESBATech, an Alcon Biomedical Research Unit LLC
- David Urech
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Stable and soluble antibodies inhibiting TNFα
- Patent number 9,683,034
- Issue date Jun 20, 2017
- ESBATech, an Alcon Biomedical Research Unit LLC
- Stefan Ewert
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Stable and soluble antibodies
- Patent number 9,598,487
- Issue date Mar 21, 2017
- ESBATech, an Alcon Biomedical Unit LLC
- Leonardo Jose Borras
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Humanization of rabbit antibodies using a universal antibody framework
- Patent number 9,593,161
- Issue date Mar 14, 2017
- ESBATech, an Alcon Biomedical Research Unit LLC
- Leonardo Jose Borras
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Solubility optimization of immunobinders
- Patent number 9,556,265
- Issue date Jan 31, 2017
- ESBATech, an Alcon Biomedical Research Unit LLC
- Leonardo Borras
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Stable and soluble antibodies inhibiting TNF alpha
- Patent number 9,422,366
- Issue date Aug 23, 2016
- ESBATech, an Alcon Biomedical Research Unit LLC
- Leonardo Borras
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Functionalized polypeptides
- Patent number 9,371,525
- Issue date Jun 21, 2016
- Esbatech, an Alcon Biomedical Reseach Unit LLC
- David Urech
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Stable and soluble antibodies inhibiting TNF alpha
- Patent number 9,315,572
- Issue date Apr 19, 2016
- ESBATech, an Alcon Biomedical Research, Unit LLC
- Stefan Ewert
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods for producing immunobinders of cell-surface antigens
- Patent number 9,221,905
- Issue date Dec 29, 2015
- ESBATech, an Alcon Biomedical Research Unit LLC
- David Urech
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
COMBINATION TREATMENT
- Publication number 20230391882
- Publication date Dec 7, 2023
- Numab Therapeutics AG
- David URECH
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
STABLE ANTIBODY VARIABLE DOMAIN FRAMEWORK COMBINATIONS
- Publication number 20230242651
- Publication date Aug 3, 2023
- Numab Therapeutics AG
- Dania DIEM
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
NOVEL ANTIBODY FRAMEWORKS
- Publication number 20230212265
- Publication date Jul 6, 2023
- Numab Therapeutics AG
- Sebastian MEYER
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
MULTISPECIFIC ANTIBODY
- Publication number 20230203162
- Publication date Jun 29, 2023
- Numab Therapeutics AG
- Peter LICHTLEN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MULTISPECIFIC ANTIBODY
- Publication number 20230192897
- Publication date Jun 22, 2023
- Numab Therapeutics AG
- David URECH
- C07 - ORGANIC CHEMISTRY
Information Patent Application
MULTISPECIFIC ANTIBODY
- Publication number 20220411536
- Publication date Dec 29, 2022
- Numab Therapeutics AG
- David Urech
- C07 - ORGANIC CHEMISTRY
Information Patent Application
NOVEL ANTI-CD3 ANTIBODIES
- Publication number 20220403028
- Publication date Dec 22, 2022
- Numab Therapeutics AG
- Tea GUNDE
- C07 - ORGANIC CHEMISTRY
Information Patent Application
HETERO-DIMERIC MULTI-SPECIFIC ANTIBODY FORMAT
- Publication number 20220332797
- Publication date Oct 20, 2022
- Numab Therapeutics AG
- Sebastian MEYER
- C07 - ORGANIC CHEMISTRY
Information Patent Application
MULTISPECIFIC ANTIBODIES HAVING SPECIFICITY FOR TNFA AND IL-17A, AN...
- Publication number 20220127350
- Publication date Apr 28, 2022
- Numab Therapeutics AG
- David Urech
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHOD FOR DECREASING IMMUNOGENICITY
- Publication number 20210214461
- Publication date Jul 15, 2021
- Novartis AG
- David Urech
- C07 - ORGANIC CHEMISTRY
Information Patent Application
NOVEL STABLE ANTIBODY VARIABLE DOMAIN FRAMEWORK COMBINATIONS
- Publication number 20200255533
- Publication date Aug 13, 2020
- Numab Therapeutics AG
- Dania DIEM
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HETERO-DIMERIC MULTI-SPECIFIC ANTIBODY FORMAT TARGETING AT LEAST CD...
- Publication number 20200181263
- Publication date Jun 11, 2020
- Numab Therapeutics AG
- David Urech
- C07 - ORGANIC CHEMISTRY
Information Patent Application
STABLE AND SOLUBLE ANTIBODIES INHIBITING VEGF
- Publication number 20200172608
- Publication date Jun 4, 2020
- Novartis AG
- Leonardo Jose Borras
- C07 - ORGANIC CHEMISTRY
Information Patent Application
NOVEL ANTI-CD3 ANTIBODIES
- Publication number 20200115449
- Publication date Apr 16, 2020
- Numab Therapeutics AG
- Tea GUNDE
- C07 - ORGANIC CHEMISTRY
Information Patent Application
HUMANIZED IMMUNOBINDERS OF CELL-SURFACE ANTIGENS
- Publication number 20190382498
- Publication date Dec 19, 2019
- Novartis AG
- David Urech
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SOLUBILITY OPTIMIZATION OF IMMUNOBINDERS
- Publication number 20190169284
- Publication date Jun 6, 2019
- Novartis AG
- Leonardo Borras
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Novel Antibody Frameworks
- Publication number 20190119359
- Publication date Apr 25, 2019
- NUMAB INNOVATION AG
- Sebastian Meyer
- C07 - ORGANIC CHEMISTRY
Information Patent Application
METHODS OF MODIFYING ANTIBODIES, AND MODIFIED ANTIBODIES WITH IMPRO...
- Publication number 20190002551
- Publication date Jan 3, 2019
- ESBATech, an Alcon Biomedical Research Unit LLC
- David Urech
- C07 - ORGANIC CHEMISTRY
Information Patent Application
STABLE AND SOLUBLE ANTIBODIES INHIBITING TNF ALPHA
- Publication number 20180371074
- Publication date Dec 27, 2018
- ESBATech, an Alcon Biomedical Research Unit LLC
- Leonardo Borras
- C07 - ORGANIC CHEMISTRY
Information Patent Application
HETERO-DIMERIC MULTI-SPECIFIC ANTIBODY FORMAT
- Publication number 20180355024
- Publication date Dec 13, 2018
- NUMAB INNOVATION AG
- Sebastian MEYER
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Bispecific Constructs and Their Use in the Treatment of Various Dis...
- Publication number 20180282419
- Publication date Oct 4, 2018
- Numab Therapeutics AG
- David Urech
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Novel Treatment Methods Based on Multifunctional Molecules
- Publication number 20180244777
- Publication date Aug 30, 2018
- Numab Therapeutics AG
- David Urech
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS FOR IDENTIFYING IMMUNOBINDERS OF CELL-SURFACE ANTIGENS
- Publication number 20180142028
- Publication date May 24, 2018
- ESBATech, an Alcon Biomedical Research Unit LLC
- David Urech
- G01 - MEASURING TESTING
Information Patent Application
HUMANIZATION OF RABBIT ANTIBODIES USING A UNIVERSAL ANTIBODY FRAMEWORK
- Publication number 20180127493
- Publication date May 10, 2018
- ESBATech, an Alcon Biomedical Research Unit LLC
- Leonardo Borras
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
STABLE AND SOLUBLE ANTIBODIES INHIBITING VEGF
- Publication number 20180072802
- Publication date Mar 15, 2018
- ESBATech, an Alcon Biomedical Research Unit LLC
- Leonardo Borras
- C07 - ORGANIC CHEMISTRY
Information Patent Application
METHOD FOR DECREASING IMMUNOGENICITY
- Publication number 20180016350
- Publication date Jan 18, 2018
- ESBATech, an Alcon Biomedical Research Unit LLC
- David Urech
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SOLUBILITY OPTIMIZATION OF IMMUNOBINDERS
- Publication number 20170096482
- Publication date Apr 6, 2017
- ESBATech, an Alcon Biomedical Research Unit LLC
- Leonardo Borras
- C07 - ORGANIC CHEMISTRY
Information Patent Application
NOVEL MULTISPECIFIC MOLECULES AND NOVEL TREATMENT METHODS BASED ON...
- Publication number 20170073415
- Publication date Mar 16, 2017
- NUMAB AG
- David URECH
- C07 - ORGANIC CHEMISTRY
Information Patent Application
BISPECIFIC CONSTRUCTS AND THEIR USE IN THE TREATMENT OF VARIOUS DIS...
- Publication number 20160368987
- Publication date Dec 22, 2016
- NUMAB AG
- David URECH
- C07 - ORGANIC CHEMISTRY
Information Patent Application
FUNCTIONALIZED POLYPEPTIDES
- Publication number 20160354479
- Publication date Dec 8, 2016
- David Urech
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...

David Urech

Person

Patents Grantslast 30 patents

Hetero-dimeric multi-specific antibody format targeting at least CD...

Hetero-dimeric multi-specific antibody format

Humanization of rabbit antibodies using a universal antibody framework

Stable and soluble antibodies inhibiting TNFα

Antibody frameworks

Stable antibody variable domain framework combinations and methods...

Anti-CD3 antibodies

Hetero-dimeric multi-specific antibody format

Solubility optimization of immunobinders

Method for decreasing immunogenicity

Stable and soluble antibodies inhibiting VEGF

Stable and soluble antibodies

Solubility optimization of immunobinders

Antibody frameworks

Stable and soluble antibodies inhibiting TNF alpha

Humanization of rabbit antibodies using a universal antibody framework

CD3 and IL-23 receptor binding bispecific constructs and their use...

Sequence based engineering and optimization of single chain antibodies

Sequence based engineering and optimization of single chain antibodies

Humanized immunobinders of cell-surface antigens

Stable and soluble antibodies inhibiting VEGF

Method for decreasing immunogenicity

Stable and soluble antibodies inhibiting TNFα

Stable and soluble antibodies

Humanization of rabbit antibodies using a universal antibody framework

Solubility optimization of immunobinders

Stable and soluble antibodies inhibiting TNF alpha

Functionalized polypeptides

Stable and soluble antibodies inhibiting TNF alpha

Methods for producing immunobinders of cell-surface antigens

Patents Applicationslast 30 patents

COMBINATION TREATMENT

STABLE ANTIBODY VARIABLE DOMAIN FRAMEWORK COMBINATIONS

NOVEL ANTIBODY FRAMEWORKS

MULTISPECIFIC ANTIBODY

MULTISPECIFIC ANTIBODY

MULTISPECIFIC ANTIBODY

NOVEL ANTI-CD3 ANTIBODIES

HETERO-DIMERIC MULTI-SPECIFIC ANTIBODY FORMAT

MULTISPECIFIC ANTIBODIES HAVING SPECIFICITY FOR TNFA AND IL-17A, AN...

METHOD FOR DECREASING IMMUNOGENICITY

NOVEL STABLE ANTIBODY VARIABLE DOMAIN FRAMEWORK COMBINATIONS

HETERO-DIMERIC MULTI-SPECIFIC ANTIBODY FORMAT TARGETING AT LEAST CD...

STABLE AND SOLUBLE ANTIBODIES INHIBITING VEGF

NOVEL ANTI-CD3 ANTIBODIES

HUMANIZED IMMUNOBINDERS OF CELL-SURFACE ANTIGENS

SOLUBILITY OPTIMIZATION OF IMMUNOBINDERS

Novel Antibody Frameworks

METHODS OF MODIFYING ANTIBODIES, AND MODIFIED ANTIBODIES WITH IMPRO...

STABLE AND SOLUBLE ANTIBODIES INHIBITING TNF ALPHA

HETERO-DIMERIC MULTI-SPECIFIC ANTIBODY FORMAT

Bispecific Constructs and Their Use in the Treatment of Various Dis...

Novel Treatment Methods Based on Multifunctional Molecules

METHODS FOR IDENTIFYING IMMUNOBINDERS OF CELL-SURFACE ANTIGENS

HUMANIZATION OF RABBIT ANTIBODIES USING A UNIVERSAL ANTIBODY FRAMEWORK

STABLE AND SOLUBLE ANTIBODIES INHIBITING VEGF

METHOD FOR DECREASING IMMUNOGENICITY

SOLUBILITY OPTIMIZATION OF IMMUNOBINDERS

NOVEL MULTISPECIFIC MOLECULES AND NOVEL TREATMENT METHODS BASED ON...

BISPECIFIC CONSTRUCTS AND THEIR USE IN THE TREATMENT OF VARIOUS DIS...

FUNCTIONALIZED POLYPEPTIDES